In vitro study on synergistic antifungal effects of docetaxel combined with azoles against dematiaceous fungi and Aspergillus niger
Frontiers in Microbiology · 17.07.2026 · 17
DOI: 10.3389/fmicb.2026.1832946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 17.07.2026. Verfasst von Heng Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hubei Provincial Clinical Research Center for Diagnosis and Therapeutics of Pathogenic Fungal Infection, Jingzhou Hospital…. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Dematiaceous fungal infections are frequently encountered in clinical practice with no unified treatment. Drug combination reduces drug resistance, and repurposed clinical drugs as synergists show promise in aiding azoles against phaeohyphomycosis.
Objective
To investigate the synergistic antifungal effects of docetaxel (DTX) in combination with azoles against dematiaceous fungi and Aspergillus niger , as well as their impact on efflux pump activity.
Methods
CLSI M38-A2 microbroth dilution method was used to detect fractional inhibitory concentration index of DTX with posaconazole (POS), itraconazole (ITC), voriconazole (VOR), and isavuconazole (ISA) against 43 fungi (including 24 strains of Exophiala dermatitidis , 7 strains of Exophiala alcalophila , 3 strains of Fonsecaea pedrosoi , 1 strain of Fonsecaea monophora , 1 strain of Exophiala verrucosa and 7 strains of Aspergillus niger ). Rhodamine 6G transport efficiency and transcriptional variations of efflux pump genes were determined in strains treated with POS alone or POS combined with DTX.
Results
DTX alone had no antifungal activity. 30/43 (69.8%) strains showed synergy with POS (87.5% E. dermatitidis , 100% A. niger ). 7 (16.3%), 3 (7.0%) and 1 (2.3%) strains showed synergy with ITC, VOR and ISA. For strains with POS synergism, DTX treatment significantly suppressed efflux activity and modified the transcription of efflux pump genes.
Conclusion
The combined scheme of DTX and POS can significantly reduce the minimum inhibitory concentration of POS and show synergistic antifungal activity, especially significant against E. dermatitidis and A. niger . Its mechanism of action may be related to the reduction of efflux pump activity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Hubei Provincial Clinical Research Center for Diagnosis and Therapeutics of Pathogenic Fungal Infection, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, Hubei, China.
- Department of Nephrology, Hubei Provincial Clinical Research Center for Diagnosis and Therapeutics of Pathogenic Fungal Infection, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, Hubei, China.
- Department of Clinical Medicine, Yangtze University, Jingzhou, Hubei, China.
Zitieren
APA
Zhang, H., Ni, H., Peng, M., Chen, T., Ge, L., Zhang, X., Tian, K., & Sun, Y. (2026). In vitro study on synergistic antifungal effects of docetaxel combined with azoles against dematiaceous fungi and Aspergillus niger. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1832946
Vancouver
Zhang H, Ni H, Peng M, Chen T, Ge L, Zhang X, et al. In vitro study on synergistic antifungal effects of docetaxel combined with azoles against dematiaceous fungi and Aspergillus niger. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1832946
BibTeX
@article{Zhang2026,
author = {Zhang, Heng and Ni, Hua and Peng, Mengqi and Chen, Tian and Ge, Lu and Zhang, Xueying and Tian, Kai and Sun, Yi},
title = {In vitro study on synergistic antifungal effects of docetaxel combined with azoles against dematiaceous fungi and Aspergillus niger},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1832946}
}
EUVIMED